Research Article

Attenuating Atherosclerosis through Inhibition of the NF-κB/NLRP3/IL-1β Pathway-Mediated Pyroptosis in Vascular Smooth Muscle Cells (VSMCs)

Figure 4

VSMCs (CRL-1999) were treated with NLRP3 inhibitor (MCC950; 2nM) for indicated time. (a) Calcium deposition in VSMCs was assessed by alizarin red S staining (positive staining: red; scale bar = 100 μm). (b) The mRNA levels of Runx2 were determined by qPCR. Data are expressed as . vs. control group; vs. AS group. (c) The protein levels of BMP2 and Runx2 were determined by western blotting. (d, e) Quantification of the results shown in (c). Data are expressed as . vs. control group; vs. AS group. (f) Representative immunofluorescent staining images for Runx2 (green) (magnification: ×400, scale bar = 20 μm).
(a)
(b)
(c)
(d)
(e)
(f)